登录

临床试验解决方案提供商MYONEX宣布收购药房服务提供商SaveWay Compounding Pharmacy,以扩大其在美国的临床试验服务

MYONEX ANNOUNCES ACQUISITION OF SAVEWAY COMPOUNDING PHARMACY TO EXPAND ITS CLINICAL TRIAL SERVICES ACROSS THE US

CISION 2024-04-09 21:10 翻译由动脉网AI生成,点击反馈

可切换为仅中文


HORSHAM, Pa., April 9, 2024 /PRNewswire/ -- Myonex, a leading global clinical trial supply company, has completed the acquisition of SaveWay Compounding Pharmacy of Newark, Del. The pharmacy will operate as SaveWay Compounding Pharmacy, a Myonex company.In further pursuit of supporting clinical trial sponsor's trial designs with direct-to-patient (DTP) and home healthcare provider (HHP) capabilities, this acquisition allows wider patient access across the entire United States, in addition to supporting patients with their access to trial medication and equipment needed..

宾夕法尼亚州霍沙姆,2024年4月9日/PRNewswire/--全球领先的临床试验供应公司Myonex已完成对新泽西州纽瓦克市SaveWay Compounding Pharmacy的收购。该药房将作为Myonex公司SaveWay Compounding Pharmacy运营。为了进一步利用直接面向患者(DTP)和家庭医疗保健提供者(HHP)的能力支持临床试验赞助商的试验设计,此次收购允许在整个美国范围内更广泛的患者访问,此外还支持患者获得所需的试验药物和设备。

Recent acquisitions of SaveWay, Creapharm accelerate Myonex's commitment to faster, flexible, more reliable service.

最近对SaveWay、Creapharm的收购加速了Myonex对更快、更灵活、更可靠服务的承诺。

Post this

发布此

'SaveWay's pharmacy capabilities complement and extend Myonex's existing clinical supplies solutions within the US. SaveWay will provide additional access for drug sourcing and direct-to-patient options across all 50 states for our clinical packaging and labelling and ancillary supply services. SaveWay complements Myonex's market-leading CTRx™ to ensure a full suite of prescription-based supply options for both investigational medicinal product (IMP) and commercial drug access throughout the US.

“SaveWay的药房功能补充并扩展了Myonex在美国现有的临床用品解决方案。SaveWay将为我们的临床包装和标签以及辅助供应服务提供更多的药物采购渠道,并为所有50个州的患者提供直接选择。SaveWay补充了Myonex市场领先的CTRx™以确保在美国各地为研究药物(IMP)和商业药物获取提供全套基于处方的供应选项。

These additional capabilities allow Myonex to better support the needs of our clients and enable decentralized clinical trials (DCT) and hybrid studies,' said James Lovett, Chief Executive Officer at Myonex..

Myonex首席执行官詹姆斯·洛维特(JamesLovett)说,这些额外的功能使Myonex能够更好地支持我们客户的需求,并实现分散临床试验(DCT)和混合研究。

'With this acquisition, Myonex will support SaveWay's expansion into clinical trials and accelerate the growth of direct-to-patient services. SaveWay has a unique opportunity to grow and expand serving patients across the US in clinical trials by dispensing investigational medicinal product, commercial medications, and specialized compounded medications directly to clinical trial patients.

“通过此次收购,Myonex将支持SaveWay向临床试验的扩展,并加速直接面向患者服务的增长。SaveWay拥有一个独特的机会,可以通过直接向临床试验患者分发研究药物、商业药物和专业复合药物,在美国各地的临床试验中为患者提供服务。

We welcome the opportunity to be part of an experienced clinical trial supply company with its roots in pharmacy. Myonex understands how we work and what we can offer to support today's trends in clinical trials,' said Pradeep Chilakapati, RPh, Managing Partner and Pharmacist at SaveWay.The recent acquisition announcement of Creapharm—and now SaveWay— accelerates Myonex's overall commitment to remain faster, more flexible, and reliable for clients while improving the clinical trial patient experience.

我们欢迎有机会成为一家经验丰富的临床试验供应公司的一部分,该公司的根基是药房。SaveWay管理合伙人兼药剂师Pradeep Chilakapati说,Myonex了解我们的工作方式以及我们可以提供什么来支持当今临床试验的趋势。最近对Creapharm和now SaveWay的收购公告加速了Myonex的整体承诺,即在改善临床试验患者体验的同时,为客户保持更快,更灵活和可靠的服务。

This growth positions Myonex as an industry partner with one of the most diverse clinical trial supply service offerings globally.Myonex was exclusively advised by Crosstree as its financial advisor and Troutman Pepper as its legal advisor in its acquisition of SaveWay. About MyonexMyonex is a leading global complete clinical trial supply company offering tailored solutions in central and local drug sourcing, packaging, labeling, and ancillary and equipment supply to support each trial's specific requirements and complexities.

这一增长使Myonex成为全球最多样化的临床试验供应服务之一的行业合作伙伴。Myonex在收购SaveWay时,由Crosstree担任其财务顾问,Troutman Pepper担任其法律顾问。关于MyonexMyonex是一家领先的全球完整临床试验供应公司,在中央和地方药物采购,包装,标签以及辅助和设备供应方面提供量身定制的解决方案,以支持每个试验的具体要求和复杂性。

With nine locations in the US, Germany, UK & France, we partner with pharmaceutical and biotechnology companies, contract research organizations (CROs), and other clinical trial service providers seeking a flexible, comprehensive solution for their trial supply needs. Learn more at www.myonex.com.About SaveWaySaveWay Compounding Pharmacy was founded as a local comm.

我们在美国、德国、英国和法国设有九个办事处,与制药和生物技术公司、合同研究组织(CRO)和其他临床试验服务提供商合作,为其试验供应需求寻求灵活、全面的解决方案。了解更多信息,请访问www.myonex.com.About Saveway Saveway Composition Pharmacy成立于当地。

推荐阅读

临床试验供应公司Myonex完成对Creapharm的收购,并扩展其全球服务

CISION 2024-05-03 09:19

临床试验供应公司Myonex将收购Creapharm的临床和商业包装及生物服务业务

businesswire 2024-03-15 15:10

天鹜科技x金赛药业:全球首款经大模型设计实现5000升工业化生产的蛋白质产品落地

动脉网 2024-06-17 13:02

CISION

5790篇

最近内容 查看更多

黄连素可治疗湿疹加重的金黄色葡萄球菌感染

3 小时前

生物技术企业家向加州大学欧文分校生物科学学院捐赠5000万美元

1 天前

驯鹿生物在EHA 2024口头演讲介绍了FUCASO®(Equecabtagene Autoleucel)治疗高危新诊断多发性骨髓瘤的新数据

1 天前

相关公司查看更多

SaveWay Compounding Pharmacy

药房服务提供商

立即沟通

Myonex

临床试验解决方案提供商

立即沟通

产业链接查看更多